• 1
    Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008. CA Cancer J Clin. 2008; 58: 130-160.
  • 2
    U.S. Preventive Services Task Force. Screening for colorectal cancer: recommendations and rationale. Ann Intern Med. 2002; 137: 129-131.
  • 3
    Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American College of Gastroenterology guidelines for colorectal cancer screening 2008. Am J Gastroenterol. 2009; 104: 739-750.
  • 4
    Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993; 329: 1977-1981.
  • 5
    Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992; 326: 658-662.
  • 6
    Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL. Natural history of untreated colonic polyps. Gastroenterology. 1987; 93: 1009-1013.
  • 7
    Haseman JH, Lemmel GT, Rahmani EY, Rex DK. Failure of colonoscopy to detect colorectal cancer. Gastrointest Endosc. 1997; 45: 451-455.
  • 8
    Pabby A, Schoen RE, Weissfeld JL, et al. Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest Endosc. 2005; 61: 385-391.
  • 9
    Robertson DJ, Greenberg ER, Beach M, et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology. 2005; 129: 34-41.
  • 10
    Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009; 150: 1-8.
  • 11
    Singh H, Turner D, Xue L, Targownik LE, Bernstein CN. Risk of developing colorectal cancer following a negative colonoscopy examination. JAMA. 2006; 295: 2366-2373.
  • 12
    Singh H, Nugent Z, Mahmud SM, Demers AA, Bernstein CN. Predictors of colorectal cancer after negative colonoscopy: a population-based study. Am J Gastroenterol. 2010; 105: 663-673.
  • 13
    Singh H, Nugent Z, Demers AA, Kliewer EV, Mahmud SM, Bernstein CN. The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology. 2010; 139: 1128-1137.
  • 14
    Brenner H, Hoffmeister M, Arndt V, Stegmaier C, Altenhofen L, Hang U. Protection from right- and left-sided colorectal neoplasms after colonoscopy: a population-based study. J Natl Cancer Inst. 2010; 102: 89-95.
  • 15
    Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology. 2007; 132: 96-102.
  • 16
    Singh H, Nugent Z, Demers A, Bernstein CN. Rate and predictors of early/missed colorectal cancers after colonoscopy in Manitoba: a population-based study. Am J Gastroenterol. 2010; 105: 2588-2596.
  • 17
    Singh A, Kuo YF, Freeman JL, et al. Colon cancer miss rates in Medicare population [abstract]. Gastrointest Endosc. 2009; 69: AB134-AB135.
  • 18
    Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data. Med Care. 2002; 40: IV–3-IV-18.
  • 19
    Rex DK, Petrini JL, Baron TH, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2006; 63: S16-S28.
  • 20
    Francis DL, Rodriguez-Correa DT, Buchner A, Harewood GC, Wallace M. Application of a conversion factor to estimate the adenoma detection rate from the polyp detection rate. Gastrointest Endosc. 2011; 73: 493-497.
  • 21
    Williams JE, Le TD, Faigel DO. Polypectomy rate as a quality measure for colonoscopy. Gastrointest Endosc. 2011; 73: 498-506.
  • 22
    Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data. Med Care. 2002; 40( suppl): 26-35.
  • 23
    Cooper GS, Payes JD. Receipt of colorectal testing prior to colorectal cancer diagnosis: a population-based study. Cancer. 2005; 103: 696-701.
  • 24
    Brenner H, Hoffmeister M, Stegmaier C, Altenhofer L, Haug U. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 810,149 screening colonoscopies. Gut. 2007; 56: 1585-1589.
  • 25
    Lindblom A. Different mechanisms of tumorigenesis of proximal and distal colon cancers. Curr Opin Oncol. 2001; 13: 63-69.
  • 26
    Sawhney MS, Farrar WD, Gudiseva S, et al. Microsatellite instability in interval colon cancers. Gastroenterology. 2006; 131: 1700-1705.
  • 27
    Harvey NT, Ruszkiewicz A. Serrated neoplasia of the colorectum. World J Gastroenterol. 2007; 13: 3792-3798.
  • 28
    Groff RJ, Nash R, Ahnen DJ. Significance of serrated polyps of the colon. Curr Gastroenterol Rep. 2008; 10: 490-498.
  • 29
    Hawkins N, Ward R. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst. 2001; 93: 1307-1313.
  • 30
    Markowitz SD, Itzkowitz SH, Berger BM. The effectiveness of colonoscopy in reducing mortality from colorectal cancer [letter]. Ann Intern Med. 2009; 150: 816-817.
  • 31
    Shah HA, Paszat LF, Saskin R, Stukel TA, Rabeneck L. Factors associated with incomplete colonoscopy: a population-based study. Gastroenterology. 2007; 132: 2297-2303.
  • 32
    Ko CW, Dominitz JA, Green P, Kreuter W, Baldwin LM. Accuracy of Medicare claims for identifying findings and procedures performed during colonoscopy. Gastrointest Endosc. 2011; 73: 447-453.
  • 33
    Baker SR, Alterman DD. False-negative barium enema in patients with sigmoid cancer and diverticulosis. Gastrointest Radiol. 1985; 10: 171-173.
  • 34
    Baxter NN, Sutradhar R, Forbes SS, Paszat LF, Saskin R, Rabeneck L. Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology. 2011; 140: 65-72.
  • 35
    Rabeneck L, Paszat LF, Saskin R. Endocopist specialty is associated with incident colorectal cancer after a negative colonoscopy. Clin Gastroenterol Hepatol. 2010; 8: 275-279.
  • 36
    Ko CW, Dominitz JA, Green P, Kreuter W, Baldwin LM. Specialty differences in polyp detection, removal, and biopsy during colonoscopy. Am J Med. 2010; 123: 528-535.
  • 37
    Ko CW, Dominitz JA, Green P, Kreuter W, Baldwin LM. Utilization and predictors of early repeat colonoscopy in Medicare beneficiaries. Am J Gastroenterol. 2010; 105: 2670-2679.
  • 38
    Rex DK. Update on colonoscopic imaging and projections for the future. Clin Gastroenterol Hepatol. 2010; 8: 318-321.
  • 39
    Paggi S, Radaelli F, Amato A, et al. The impact of narrow band imaging in screening colonoscopy: a randomized controlled trial. Clin Gastroenterol Hepatol. 2009; 7: 1049-1054.
  • 40
    Soetikno RM, Kaltenbach T, Rouse RV, et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA. 2008; 299: 1027-1035.
  • 41
    Schenck AP, Klabunde CN, Warren JL, et al. Data sources for measuring colorectal endoscopy use among Medicare enrollees. Cancer Epidemiol Biomarkers Prev. 2007; 16: 2118-2127.
  • 42
    Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998; 280: 1747-1751.
  • 43
    Cooper GS, Xu F, Koroukian S, Barnholtz-Sloan J, Schluchter M. Colorectal cancer diagnosis without colonoscopy: frequency and predictive factors [abstract]. Paper presented at: Digestive Disease Week 2010; May 1-5, 2010; New Orleans, La.